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The subjects of liver transplantation and portal 
hypertension are inseparable. Portal venous hyper-
tension is present in the vast majority of patients 
who become candidates for liver transplantation. 
Furthermore, previous operations on the portal 
venous system, including portosystemic shunts, can 
greatly complicate the performance of subsequent 
liver transplantation. Finally, the provision of the 
new liver with an adequate splanchnic venous flow is 
a vital objective of all planning in every transplant 
operation, whether the graft is placed in the natural 
location (orthotopic) or at an ectopic site (auxiliary 
transplantation). These specific issues of the portal 
circulation are considered separately here. 
THE RELIEF OF PORTAL HYPERTENSION 
WITH TRANSPLANT A liON 
Discussions are limited in this chapter to those 
patients whose portal hypertension has been caused 
by the sinusoidal intrahepatic block that is typical of 
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chronic liver disease. Patients with extrahepatic Por 
tal vein thrombosis and cavernous transformation 0; 
postsinusoidal block such as Budd-Chiari syndrome 
may come ~o t~ansplantationI but this is uncommon. 
ComplIcatIOns of the venous hypertension that 
can be palliated by portosysteI?1ic shunts are hemor_ 
rhage from esophageal vances and intractable 
ascites. With potent and specific diuretic drugs and 
with the availability of antialdosterone agents 'truly 
intractable ascites is extremely uncommon. When it 
does occur, more appropriate therapy than portosyS-
temic shunt often will be a peritoneal jugular shunt 1 
Thus, the principal problem about which therape~_ 
tic judgments must be made in planning relief of 
portal hypertension is hemorrhage from esophageal 
varices. The preponderance of affected patients have 
variable degrees of liver failure. A shunting proce-
dure often will make the liver failure worse, even if it 
is successful in controllin~ t~e variceal hemorrhage. 
In contrast, orthotOPIC liver transplantation is a 
spectacularly effective way to treat portal hyperten_ 
sion. During the preliminary phases of the operation 
and during dissection of the portal triad structures 
bleeding from the thin-walled and often widely rus: 
tributed varices can be quite alarming. This problem 
usually can be ameliorated, even during the time 
when the diseased liver is being removed and the 
patient is anhepatic. The use of a venovenous bypass 
during this time provides prompt relief by reducing 
the portal hypertension (Fig. 1). 
If the new liver is a good one, it will readily 
transmit the portal venous flow, and, within a matter 
of minutes, the previously high-pressure venous col-
lateral channels are deflated. If very large collateral 
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Figure 1 Venovenous bypass 
allows decompression of the 
splanchnic and systemic ve-
nous beds during the anhe-
patic phase without the need 
for heparinization. (Adapted 
with permission of Griffith et 
a!. Surg Gynecol Obstet 1985; 
160:270-272.) 
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'f.ble 1 Survival Comparison Among Various Treatments for Bleeding Esophageal Varices (Qli]d's Oass A. B, and C) 
-- No. of 
Study Patienls 1 year 
-Langer et aI (1985) 
38 80-Selective shunt 
Nonselective shunt 40 90* 
Millikan et aI (1985) 
26 85-Selective shunt 
Nonselective shunt 29 80-
warren et aI (1986) 
Sderotherapyt 36 90* 
Selective shunt; 35 70-
Rikkers et aI (1987) 
Sclerotherapy 30 77· 
Selective shunt; 27 75· 
lwatsuki et aI (1988) 
Liver transplantation 302 79 
-Value estimated from survival curve. 
tSclerotherapy failures were rescued by surgical therapy. 
tTwenly-three selective shunts and four nonselective shunts. 
vessels, usually coronary veins, are encountered, 
these can be ligated, to encourage bepatopetal 
splanchnic flow, but these extra maneuvers may not 
be necessary, and in some cases, they may be med-
dlesome. 
Liver substitution has been studied in patients 
who had severe liver failure in addition to a history 
of bleeding esophageal varices, or who were actively 
bleeding.2 The survival rates of 302 such patients 
were 79 percent at 1 year, 74 percent at 2 years, and 
71 percent at 3, 4, and 5 years after liver transplanta-
tion. These excellent results were obtained regardless 
of the cause of cirrhosis, including alcoholism. 
The results achieved by liver transplantation 
were compared with those in four well-studied con-
Survival Rates (96) 
2 yetJrs - 3 yetJrS 4 years 5 years 
76- 63- 54- 51-
85- 70- 56- 56-
77· 65· 60- 55-
n- 70- 65- 60-
84- 82- 82-
59- 45· 45· 
61· 60- so-
65· 60- 39-
74 71 71 71 
trol trials reported since 1985 (Table I). More than 
75 percent of the patients in each report listed in 
Table 1 had good or fair hepatic function (Child's 
class A and B) before the shunting procedure, 
whereas all of the patients treated with liver trans-
plantation had poor or very poor hepatic function 
(Child's class C). Despite this severe disadvantage of 
preoperative condition, the survival rates after liver 
transplantation were better than or similar to those 
of patients who underwent shunt operation. 
When the results were compared only among 
the patients with advanced hepatic dysfunction 
(Child's class C), the survival rates with liver trans-
plantation were far better than those achieved by 
shunt operations (Table 2). These comparative data 
Table 2 Survival Comparison Among Various Treatments for Bleeding Esophageal Varices 
(Child's Oass C, Poor Liver Function) 
No. of 
Study Patients 1 year 
Turcotte et aI (1973) 
Nonselective shunt 50 36 
Warren et aI (1982) 
Selective shunt ? 60-
Nonselective shunt ? so-
Rikkers et aI (1984) 
Shunt and nonshunt operationst 24 45· 
Chandler et aI (1985) 
phun~ 30 36· 
lwatsuki et aI (1988) 
Liver transplantation 302 79 
-Value estimated from survival c:une. 
tFifteen nonselective shunts. seven selective shunts, and two Donshunt opcntiODS. 
fBoth selective and nonselective operations. 
Survival RaJes (%) 
2 years 3 years 4 years 5 years 
32 22 20 17 
53- 45- 40- 35-
40- 37· 20- IS-
35· 30- 20- 17-
30- 25- 20- 13· 
74 71 71 71 
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were particularly striking because the liver recipients 
were considered too advanced in their liver disease 
to be considered for shunting operations. 
However the concept of performing a liver transplantati~n for every patient who has signifi~nt 
variceal hemorrhage would be a grotesque oversIm-
plification of the meaning of these studies. Instead, 
the data have stimulated a re-examination of pre-
viously used therapy, including shunt operations. 
Such operations can be used in selected patients, 
although these operations may influence the ulti-
mate step of transplantation. 
THE EFFECT OF PREVIOUS UPPER 
ABDOMINAL OPERATIONS 
Nonshunt Procedures 
Somewhat surprisingly, previous operations in 
the upper abdomen, exclusive of those on the 
splanchnic circulation, have not precluded good re-
sults after subsequent transplantation.3 However, 
the need for transfusion and the average technical 
difficulty in these patients are greatly increased. 
The performance of operations such as the 
Kasai procedure that increase adhesions and pro-
mote collateral circulation may have an adverse ef-
fect on the operability of children with biliary atre-
sia. After portoenterostomies, the portal vein in 
many children has undergone atresia apparently be-
cause the collateral vessels in adhesions "steal" por-
tal flow. When transplantation eventually is per-
formed, the graft portal vein often must be 
anastomosed to the confluence of the splenic and 
superior mesenteric veins because the native portal 
vein is frequently atretic above this level. In such 
cases, ligation of large collateral vessels, particularly 
the coronary vein, may be important to ensure good 
portal blood flow. So far, the mortality after liver 
transplantation has not been significantly different 
in children who have undergone portoenterostomy 
than in those who have not. However, with the ac-
quisition oflarger numbers, it is probable that the 10 
percent to 15 percent increased operative mortality 
in patients with. biliary atresia and Kasai operations 
will become significant. 
operations to interrupt periesophageal collateral 
vessels for decompression of esophageal varices (Su-
giura's operation) may create such vascular adhe-
sions in the upper abdomen that transplantation be-
comes almost impossible. 
Previous splenectomy, an operation used in the 
past to decrease splanchnic blood flow, was the most 
common condition associated with portal vein ab-
normalities encountered during liver transplanta_ 
tion.· The usual situation was that thrombi had 
propagated retrograde from the ligated splenic vein, 
which often extended all the way to the confluence 
with the superior mesenteric vein. 
Previous Shunt Procedures 
Before the use of cyclosporine, beginning in 
1980, nearly a third of our 170 transplant recipients 
had undergone previous portosystemic shunt place-
ment. S The most common were end-to-side or side-
to-side portacaval shunts in the hilum, but there 
were a number of examples of proximal or distal 
splenorenat shunts, H-graft mesocaval shunts, or ca-
vomesenteric (Marion) shunts. The presence of any 
of these shunts was thought to be a highly disadvan-
tageous condition, probably with justification. 
In the cyclosporine era, the number of patients 
with shunts has been less. Over a period of 9 years, 
from March 1980 to March 1989, 58 liver recipients 
had previous shunts (Table 3). The most common 
variety was the distal splenorenal shunt (DSRS = 18 
cases), followed by mesocaval shunt (MeS = 17 
cases), portacaval end-to-side shunt (PCE-S = 11 
cases), portacaval side-to-side and proximal spleno-
renal shunt (PCS-S = 5 cases and PSRS = 7 cases) 
Lerut et at· noted that abnormalities in the portal 
vein leading to significant complications after trans-
plantation were high in this subset of patients. Pa-
tients with previous portosystemic shunt procedures 
have a complicating set of technical and anatomic 
factors that render the actual performance of liver 
Table 3 Characteristics of 58 Liver Recipients with Previous Portosystemic Shunt 
Kind of 
Previous Shunt 
Portal venous-maintaining 
Distal splenorenai 
Portal venous-diverting 
Mesocaval 
Portacaval end-to-side 
Portacaval side-to-side 
Proximal sp\enorenai 
OL Tx - Orthotopic liver transplantation. 
11 1S&&&&&22 
No. of 
Cases 
18 
17 
11 
5 
7 
Age in years 
(Median/range) 
40.9 (12-61) 
38.5 (7-56) 
41.6 (4-51) 
31.6 (20-64) 
21.0 (21-41) 
Interval 
Shunt-OLTx 
(years. mean ± SD) 
5.6 ±0.9 
5.1 ±O.9 
7.7 ± 2.5 
3.5 ±O.7 
7.9 ± 1.9 
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transplantation more challenging. However, the re-
sults still have been good enough to justify continu-
ing efforts at treatment of these patients. 
In our case material there were 26 males and 32 
females, with a mean age of 39.2 ± 13 years (range 4 
to 64 years).6 Twenty-three patients were Child's 
class Band 35 were Child's class C at the time of the 
pre-orthotopic liver transplantation evaluation. All 
patients were immunosuppressed with cyclosporine 
and prednisone7 to which azathioprine and OKT3 
were added when clinically required. Postnecrotic 
and primary biliary cirrhosis accounted for 45 per-
cent of the cases. The mean interval between the 
shunt procedure and orthotopic liver transplantation 
was approximately 6 years. This averaged 3.5 years 
in the side-ta-side portosystemic shunt group and 
7.9 years in patients belonging to the proximal 
splenorenal group. 
There was not a statistically significant differ-
ence in the actuarial 9-year survival between patients 
who underwent previous portosystemic shunt before 
transplant and those who did not (Fig. 2). Sixty-
seven percent of the portosystemic shunt patients 
were alive 5 years after orthotopic liver transplanta-
tion, whereas the survival at the same time interval 
was 65 percent in the rest of all liver transplant 
recipients. 
Age and sex did not influence the outcome nor 
did shunt patency at the time of orthotopic liver 
transplantation. The presence of an atrophic or 
sclerotic portal vein or use of vein or arterial graft 
did not have a statistical impact on either graft or 
patient survival. The graft survival was significantly 
different between patients classified as Child's Band 
Child's C. However, because of timely retransplan-
Figure 2 Survival of portosys-
temic shunt (PSS) patients 
(N = 58) versus the entire 
nonPSS population (N = 1445) 
transplanted in a 9-year period 
of cyclosporine immunosup-
pression. No statistical differ-
ence is noted. (Reproduced by 
pennission of Mazzaferro et al. 
Am J Surg 1990; 160: 111-116.) 
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tation in cases of graft failure, no significant differ-
ence was observed in patient survival, which was 74 
percent for the Child's B group and 67 percent for 
the Child's'C group. 
The first ten patients of the series (1980- 1982) 
did not have the advantage of the intraoperative 
venovenous bypass system (Bia-pump).& In a second 
group of 24 patients (l983-October 1987), the na-
tive hepatectomy was performed under bypass con-
ditions. In those patients at least a single cavacaval 
bypass was always used, and the portal limb of the 
system was added whenever allowed by the intraop-
erative conditions of the portal vein and the previous 
shunt. In a third group of 24 patients (October 
1987 - March 1989) the venous bypass was em-
ployed and, in addition, the University of Wisconsin 
solution was used for graft preservation, replacing 
the Collins solution previously employed. 
The use of venovenous bypass probably reduced 
intraoperative blood loss and may have contributed 
to a shorter operative time when compared to the 
first patients of the series in which bypass was not 
used. 
With the introduction of the University of Wis-
consin preservation solution, there was a signifi-
cantly longer cold ischemia time of the graft, but the 
postreperfusion liver function was improved.9 The 
longer and more effective preservation allowed more 
detailed planning of the operation, with better con-
trol of the bleeding and elimination of haste in re-
perfusing the organ. These facts are reflected in a 
further decrease in blood loss and intensive care unit 
stay. The actuarial survival also improved signifi-
cantly.6 
The kind of previous shunt had an impact on 
PSS 
NON-PSS 
o ~--~----~----~----~--~----~----~--~------
o 2 ., 
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4 
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survival (Fig. 3). Previous shunt procedures with no 
liver hilum dissection were safer. Patients with me-
socaval and DSRS patients had 5-year and 9-year 
survivals of 95 percent and 87 percent, respectively, 
whereas any other previous shunt was not associated 
with a survival better than 52 percent at the same 
time intervals. Those differences were highly signifi-
cant. 
Our cumulative experience suggests that al-
though either previous shunts, portal vein abnormal-
ities, or the need for portal vein reconstruction sig-
nificantly increase the complexity of the procedure 
as detennined by the operative time and blood loss, 
these conditions do not prohibit successful hepatic 
transplantation. 
TRANSPLANTATION VERSUS SHUNTS: 
A MIDDLE GROUND 
Should shunting operations ever be recom-
mended as treatment for variceal hemorrhage, 
knowing that these procedures can jeopardize, or at 
least make more difficult, the ultimate step of liver 
transplantation? Probably uncommonly, because 
endoscopic sclerosis of varices is an effective alterna-
tive. In some patients with Child's class A cirrhosis, a 
DSR anastomosis may be preferred to relieve portal 
hypertension. We are using this approach in a small 
number of highly selected patients. Although the 
portal vein eventually diminishes in size as a result 
of the Warren shunts, presumably because of the loss 
of flow, portal flow can be restored at the end of the 
transplantation by perfonning splenectomy. which 
functionally removes the shuDt. 6,10 
The obvious limitations of the shunt approach 
to variceal bleeding have greatly reduced the fre-
Mes 
OSRS 
pesos 
Figure 3 Influence of previous shunts on 
survival after liver transplantation. Meso-
caval and distal splenorenal shunt had a 
significant positive impact on survival 
when compared with other shunts. 
(MCS = mesocaval; DSRS = distal splen-
orenal; PSRS = proximal splenorenal; 
PCS-S = portacaval side-ta-side; PCE-S = 
portacaval end-ta-side). (Reproduced by 
permission of Mazzaferro et al. Am J Surg 
1990; 160: III - 116.) 
Quency of portal diversion procedures in Western 
countries. Instead of shunting, more and more reli-
ance has been placed on sclerotherapy, to the extent 
that the pendulum may have swung too far. Sclero-
therapy has its own special dangers, including esoph-
ageal perforation and ulceration or stricture of the 
distal esophagus. 
EXTRA-ANATOMIC PORTAL VEIN 
REVASCULARIZA TlON 
Until recently, thrombosis of the portal vein or 
of its principal tributaries, the splenic and superior 
mesenteric veins, was thOUght to be a contraindica-
tion to transplantation. However, newly developed 
vein graft techniques routinely allow liver replace-
ment in such patients II (Fig. 4). The vein grafts are 
routed from the superior mesenteric vein below the 
transverse mesocolon, brought anterior to the pan-
creas, and used for portal anastomosis in the hepatic 
hilum. 
PORTAL DECOMPRESSION THROUGH 
AN AUXILIARY GRAFT 
An option to liver replacement is transplanta-
tion of an. extra liver in an ectopic site, or auxiliary 
transplantation. This operation was envisioned by 
Welch as treatment for patients with end-stage cir-
rhosis.12 With the auxiliary operation as originally 
described in unmodified dogs, the extra liver was 
placed in the right paravertebral gutter, rearterialized 
from convenient adjacent vessels, and provided with 
the portal venous inflow with systemic blood from 
the recipient iliac vein or inferior vena cavall (Fig. 
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Donor portal v 
Figure 4 Vein graft from the superior mesenteric vein to 
the portal vein in a case of portal vein thrombosis. The 
graft is brought anterior to the pancreas and beneath the 
pylorus. (Reproduced by permission ofTzakis et aI. Trans-
plantation 1989; 48:530-531.) 
5). The graft outflow was drained into the recipient 
inferior vena cava. It was soon observed that auxil-
iary grafts were much more severely damaged than 
were orthotopica1ly placed ones, primarily because 
of rapid hepatocyte atrophy.14 
These adverse effects could be prevented by di-
verting splanchnic venous flow through the auxiliary 
liver and away from the recipient's own liver!" sug-
gesting that the splanchnic venous blood contained 
specific liver-supporting factors. The most impor-
tant of these so-called portal hepatotropic substances 
is insulin. 15 
The experiments suggested that an auxiliary 
liver graft could not function optimally without 
splanchnic venous inflow. The condition of provid-
ing such blood to the new liver has been met in 
almost all of the subsequent clinical trials which, by 
1988, included about 60 patients. By providing this 
advantage to the transplant, the additional objective 
has been incidentally met of decompressing the por-
tal system through the interposed graft. In other 
words, the graft has become part of a portosystemic 
shunt. 
Two patients from the distant past had unques-
tionable prolongation of life after auxiliary trans-
I 
/ 
~- -J_ 
Figure 5 Auxiliary liver transplantation in dogs. The 
extra liver is provided with the portal inflow with systemic 
blood from the recipient inferior vena cava. Rapid hepato-
cyte atrophy occurred in the auxiliary graft because the 
splanchnic venous flow does not contribute to the graft 
portal inflow. (Reproduced by permission of StanI TE. 
Experience in hepatic transplantation. Philadelphia, WB 
Saunders, 1969.) 
plantation. The first, a child with biliary atresia, is 
alive with a follow-up of more than 16 years. 16 A 
second patient in Paris lived for more than 8 years 
after auxiliary transplantation but then died from a 
hepatocellular carcinoma in the diseased host liver. 17 
With the increasing success of orthotopic liver 
transplantation, interest in auxiliary transplantation 
waned. II The resulting pessimism has been lightened 
by a recent report of the transplantation of whole 
livers or liver fragments to the right paravertebral 
gutter of six adults using essentially the same opera-
tion that was tried in earlier times (Fig. 6). At the 
time of reporting with follow-ups of 5 to 23 months, 
all six recipients are alive. 19 With these imprOVed 
results, further cautious trials are certain to be forth-
coming. 
I 
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-KKK~-IKKKK- Celiac axis 
graft 
Figure 6 Auxiliary liver transplant in humans. Note that 
the auxiliary graft receives portal flow from the splanchnic 
venous system and is drained into the inferior vena cava. 
(Reproduced by permission of Starzl TE. Experience in 
hepatic transplantation. Philadelphia: WB Saunders, 
1969.) 
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obstruction can be extrahepatic, intrahepatic, or su-
prahepatic. Suprahepatic obstruction (Budd-Chiari 
syndrome) is extremely rare in childhood, and is 
usually caused by obstruction of the hepatic veins or 
the suprahepatic vena cava A specific etiology is 
usually not identified. Budd-Chiari syndrome usu-
ally follows a slow indolent course, during which 
ascites and portal hypertension, with its complica-
tions, develop. Most patients ultimately die from 
hepatic failure or variceal bleeding. Portosystemic 
shunts have been used with varying results to treat 
this condition. Mesoatrial shunts have also been 
used on occasion to treat the portal hypertension. If 
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